Obesity and the Metabolic Syndrome
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
A 63-year-old Mexican-American woman presents to the emergency department stating that for the past several nights she has had to sleep sitting up in a reclining chair because of difficulty breathing when lying in bed. She also reports that her legs have been swollen lately. She had no other complaints and no history of hypertension or diabetes. On physical examination, her height was 5 ft 3 in (1.5 m), weight 250 pounds (112.5 kg) and blood pressure 130/80 mm Hg. Rales were heard at the bases of her lungs; heart rate was 96 beats/minute, there was an S3 and S4 gallop and a grade 2/6 mid to late systolic mitral valve murmur. She had 2+ pretibial and ankle pitting edema. A lipid profile showed levels all within the American Heart Association/American College of Cardiology guidelines. An electrocardiogram revealed evidence of left ventricular hypertrophy with repolarization changes. An echocardiogram revealed left ventricular hypertrophy and dilatation and mild to moderate mitral regurgitant flow.A 45-year-old white man presents to his primary healthcare provider for a routine physical examination. He has no complaints and considers himself to be in good health. On physical examination his height was 5 ft 10 in (1.78 m), weight 220 pounds (99 kg), and blood pressure 155/95 mm Hg. The remainder of the examination was unremarkable. His blood work revealed a fasting blood sugar of 160 mg/dL (8.9 mmol/L), hemoglobin A1C 8.1%, cholesterol 265 mg/dL (6.85 mmol/L), high-density lipoprotein (HDL) 35 mg/dL (0.91 mmol/L), low-density lipoprotein (LDL) 185 mg/dL (4.78 mol/L), triglycerides 250 mg/dL (2.82 mmol/L), and very low density lipoprotein (VLDL) 52 mg/dL (1.34 mmol/L). Results of liver and renal function tests were within the normal range. The urine was positive for albumin. A diagnosis of the metabolic syndrome was made. A low-calorie, low in sodium, cholesterol, and carbohydrates diet was ordered, in addition to an exercise regimen. The recommended medications were a statin, a diuretic, an angiotensin-converting enzyme inhibitor, a β-blocker, and an oral hypoglycemic agent (metformin). He had heard the news about leptin, a fat hormone, and asked whether this new hormone could help him lose weight.1. d. 61%Obesity is currently the focus of public health officials because of the alarming rate of increase in the number of overweight people in all age groups in the United States. Obesity is reaching epidemic proportions in the United States; statistically we are the fattest country in the world. Obesity is defined by the BMI, as weight in kilograms divided by the square of the height in meters (kg/m2). The World Health Organization (WHO) classifies overweight as a BMI greater than or equal to 25, obesity as a BMI greater than or equal to 30, and extreme obesity as a BMI greater than or equal to 40. Studies by the National Health and Nutritional Examination Center has shown an upper trend in the prevalence of obesity in the adult populations, particularly in the past 20 years. It is estimated that 61% of adults in the United States (20 to 74 years) are either obese or overweight, 27% are obese, and 34% are overweight.1,2 There is a frightening obesity trend in young American children, which should be a wake-up call to a public health problem that we will be facing 10 to 50 years from now when these youngsters become old enough to be at risk of CAD, heart failure, and stroke. In the past 2 decades, the prevalence of obesity has doubled in children and tripled among adolescents. Among children 6 to 11 years old 13% are overweight, and among children 12 to 19 years old 14% are overweight. The increase in obesity has been more dramatic in black and Mexican American children and adolescents: about 70% of obese preadolescent children remain obese as adults.32. a. waist circumferenceAlthough the association of obesity to CV risk factors such as type II diabetes mellitus, hypertension, and hyperlipidemia is well known, it is puzzling that some very obese persons have normal blood pressures and normal blood glucose levels and lipid profiles. Part of the problem may be related to the method used to measure obesity. It is currently recognized that body fat distribution has important health implications. Central abdominal adiposity has a stronger association with CV risk factors than peripheral obesity and is more predictive of coronary events. Since an accurate measurement of body fat is both costly and impractical, most studies have used the BMI as a surrogate measurement. Although the BMI is a fairly accurate representation of the degree of obesity, the relation between BMI and adipose tissue mass in women differs from that in men and varies with age. In addition, BMI does not convey information on body size.4 Other studies have used the WHR as an index of visceral adiposity. However, WHR predicts visceral adipose tissue volume with an error of at least 15% to 20%. Some authors consider waist circumference as the best predi
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000
Ogden, C. L. (2002) · JAMA · doi:10.1001/jama.288.14.1728 · Cited by 4,060
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Impact of Overweight on the Risk of Developing Common Chronic Diseases During a 10-Year Period
Field, A. E., Coakley, E. H., Must, A., Spadano, J. L., Laird, N., Dietz, W. H., Rimm, E., & Colditz, G. A. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1581 · Cited by 1,694
Obesity Accelerates the Progression of Coronary Atherosclerosis in Young Men
McGill, H. C., McMahan, C. A., Herderick, E. E., Zieske, A. W., Malcom, G. T., Tracy, R. E., & Strong, J. P. (2002) · Circulation · doi:10.1161/01.cir.0000018121.67607.ce · Cited by 684
Abnormal regulation of the leptin gene in the pathogenesis of obesity.
Ioffe, E., Moon, B., Connolly, E., & Friedman, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11852 · Cited by 117
Cited by
Socransky, S. S., & Haffajee, A. D. (2005) · Periodontology 2000 · doi:10.1111/j.1600-0757.2005.00107.x · Cited by 1,691
Metabolic syndrome: definitions and controversies
Kassi, E., Pervanidou, P., Kaltsas, G., & Chrousos, G. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-48 · Cited by 1,565
Fructose, insulin resistance, and metabolic dyslipidemia
Basciano, H., Federico, L., & Adeli, K. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-5 · Cited by 832
Mangiafico, S., Costello-Boerrigter, L. C., Andersen, I. A., Cataliotti, A., & Burnett, J. C. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs262 · Cited by 276
Lee, Y. M., Choi, J. S., Kim, M. H., Jung, M. H., Lee, Y. S., & Song, J. (2006) · Nutrition · doi:10.1016/j.nut.2005.12.014 · Cited by 116
Metadata
- Authors
- Keller, K. B., & Lemberg, L.
- Venue
- American Journal of Critical Care
- Publisher
- AACN Publishing
- Published
- 2003-03-01
- Volume
- 12
- Issue
- 2
- Pages
- 167-170
- ISSN
- 1062-3264 (ISSN-L)
- 1937-710X
- OpenAlex
- W2185225136
- Cited by
- 137
- References
- 6
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Obesity and the Metabolic Syndrome. https://app.cochat.ai/papers/10.4037/ajcc2003.12.2.167
- The paper
- Keller, K. B., & Lemberg, L. (2003). Obesity and the Metabolic Syndrome. American Journal of Critical Care. https://doi.org/10.4037/ajcc2003.12.2.167
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.